{"gene":"PICALM","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2015,"finding":"PICALM regulates clathrin-dependent internalization of Aβ bound to LRP1 at the blood-brain barrier and guides Aβ trafficking through Rab5 and Rab11 endosomal compartments, leading to transcytosis and clearance of Aβ across brain endothelium. Endothelial PICALM deficiency diminishes Aβ clearance and accelerates Aβ pathology, reversible by endothelial PICALM re-expression.","method":"Human brain endothelial monolayers, Picalm-deficient mice, adenoviral PICALM re-expression, iPSC-derived endothelial cells, live imaging, immunofluorescence","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vivo mouse KD, human endothelial monolayers, iPSC cells, adenoviral rescue), replicated across cell and animal models in single rigorous study","pmids":["26005850"],"is_preprint":false},{"year":2014,"finding":"PICALM/CALM modulates autophagy by regulating the endocytosis of SNARE proteins VAMP2, VAMP3, and VAMP8, which affect distinct stages of autophagy from autophagosome formation to degradation. CALM overexpression or depletion alters tau clearance (an autophagy substrate) both in vitro and in vivo in zebrafish transgenic models.","method":"siRNA knockdown, overexpression in cell lines, zebrafish transgenic models, endocytosis assays for SNARE proteins","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (in vitro knockdown/OE plus in vivo zebrafish model), identified specific SNARE substrates mechanistically linking PICALM to autophagy stages","pmids":["25241929"],"is_preprint":false},{"year":2013,"finding":"PICALM forms a complex with adaptor protein AP2 that functions as an autophagic cargo receptor; AP2/PICALM binds LC3 (identified by affinity purification/mass spectrometry) and cross-links LC3 with APP-CTF, directing APP-CTF from the endocytic pathway to autophagic degradation. AP2 knockdown reduces autophagy-mediated APP-CTF degradation.","method":"Affinity purification followed by mass spectrometry, co-immunoprecipitation, siRNA knockdown, live imaging","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — AP/MS identification confirmed by co-IP and live imaging, multiple orthogonal methods in single study","pmids":["24067654"],"is_preprint":false},{"year":2012,"finding":"PICALM co-localizes with APP in intracellular vesicles after endocytosis. PICALM knockdown reduces APP internalization and Aβ generation; PICALM overexpression increases APP internalization and Aβ production. In vivo AAV-mediated PICALM manipulation in APP/PS1 mice bidirectionally alters soluble and insoluble Aβ levels and amyloid plaque load.","method":"siRNA knockdown, PICALM overexpression in N2a-APP cells, AAV8 gene transfer (shRNA and cDNA) in APP/PS1 mice, colocalization imaging, ELISA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional manipulation (KD and OE) in cell and in vivo mouse models with quantitative Aβ readouts","pmids":["22539346"],"is_preprint":false},{"year":2013,"finding":"PICALM is abnormally cleaved in AD brains by calpain or caspase (demonstrated in vitro); full-length PICALM is decreased in AD. PICALM co-localizes with neurofibrillary tangles containing conformationally abnormal hyperphosphorylated tau, and PHF-tau proteins co-immunoprecipitate with PICALM.","method":"Western blotting with anti-PICALM antibodies, in vitro calpain/caspase activation assay, immunohistochemistry, co-immunoprecipitation","journal":"Acta neuropathologica","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — co-IP and in vitro cleavage assay plus IHC, single lab but multiple orthogonal methods","pmids":["23589030"],"is_preprint":false},{"year":2012,"finding":"PICALM plays a critical role in transferrin receptor (TfR) internalization and iron homeostasis. PICALM-deficient MEFs show increased surface TfR expression, decreased intracellular iron, and reduced proliferation, all rescued by retroviral PICALM re-expression. C-terminal PICALM residues are critical for clathrin association and inhibitory effect on TfR internalization.","method":"PICALM overexpression and knockdown/deficient MEFs from fit1 mice, retroviral rescue, flow cytometry, iron supplementation experiments, C-terminal deletion mutants","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — bidirectional manipulation with retroviral rescue, domain mutagenesis, multiple orthogonal readouts in single study","pmids":["22952941"],"is_preprint":false},{"year":2012,"finding":"CALM/PICALM is required for clathrin-mediated endocytosis of transferrin and for erythroid maturation in mice. CALM-deficient mice exhibit severe anemia and impaired iron content in erythroid precursors; CALM-deficient erythroid cells and embryonic fibroblasts show impaired clathrin-mediated transferrin endocytosis.","method":"CALM-deficient mouse model, transferrin endocytosis assays in erythroid cells and embryonic fibroblasts, histological analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout mouse model with specific cellular endocytosis readouts, replicates findings from parallel study (PMID:22952941)","pmids":["22363754"],"is_preprint":false},{"year":2014,"finding":"PICALM PIP2-binding domain is necessary for transferrin receptor endocytosis in erythroblasts and absolutely essential for erythroid development. PICALM functions as a cell-type-specific regulator of transferrin receptor endocytosis in erythroid cells, and is required for efficient clathrin coat maturation (shown by freeze-etch EM). Picalm deletion abrogates disease phenotype in a Jak2(V617F) polycythemia vera mouse model.","method":"Conditional Picalm knockout mice, PIP2-binding domain mutant, freeze-etch electron microscopy, live-cell imaging, erythroid culture system, Jak2(V617F) knock-in mouse model","journal":"Haematologica","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — conditional KO mice with domain mutagenesis, structural imaging (freeze-etch EM), and disease model rescue; multiple orthogonal methods","pmids":["25552701"],"is_preprint":false},{"year":2018,"finding":"PICALM physically associates with both ABCB1/P-glycoprotein and LRP1 at brain endothelium (shown by co-immunoprecipitation and co-immunostaining), functionally linking these two Aβ clearance proteins and guiding their coordinated transcytosis of Aβ through endothelial cells.","method":"Co-immunoprecipitation, co-immunostaining, dual inhibition of ABCB1/P-gp and LRP1","journal":"Brain, behavior, and immunity","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP and co-immunostaining with functional dual-inhibition experiment, single lab","pmids":["30041013"],"is_preprint":false},{"year":2016,"finding":"PICALM depletion by siRNA in H4 neuroglioma cells reduces functional clathrin-mediated endocytosis (measured by Alexa488-transferrin uptake), reduces intracellular APP, β-CTF, and secreted sAPPβ, and decreases BACE1 mRNA and protein levels. PICALM depletion alters intracellular distribution of clathrin.","method":"siRNA knockdown of PICALM and clathrin, Western blotting, ELISA, immunohistochemistry, flow cytometry for transferrin uptake","journal":"BMC neuroscience","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple readouts (endocytosis assay, Western blot, ELISA) in single lab, human brain-derived cell line","pmids":["27430330"],"is_preprint":false},{"year":2019,"finding":"PICALM interacts with APP via the APP NPXY-motif (interaction abolished by NPXY mutation, shown by co-immunoprecipitation). PTB-domain-containing adaptor proteins Numb, JIP1b, and GULP1 interact with PICALM and enhance the APP-PICALM interaction. Co-expression of distinct PTB-APs differentially alters APP cell surface levels, endocytosis rates, and PICALM nuclear shuttling.","method":"Co-immunoprecipitation with APP NPXY-motif mutation, FACS analysis, internalization assays, fluorescence microscopy for nuclear localization","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — co-IP with mutagenesis of APP NPXY motif plus functional endocytosis assays, single lab","pmids":["31300465"],"is_preprint":false},{"year":2020,"finding":"Increased expression of PICALM (or its yeast homolog Yap1802p) rescues APOE4-induced endocytic defects in human iPSC-derived astrocytes, demonstrating a functional interaction between two AD risk factors centered on endocytosis. In yeast, APOE4 expression causes dose-dependent defects in endocytosis and growth that are rescued by Yap1802p overexpression.","method":"iPSC-derived human astrocytes (isogenic APOE3/APOE4), yeast model with APOE4 expression, Yap1802p overexpression, endocytosis assays","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue in both yeast and human iPSC-derived astrocytes, two orthogonal model systems, single lab","pmids":["33027662"],"is_preprint":false},{"year":2020,"finding":"Picalm haploinsufficiency in Tg30 tau transgenic mice (Tg30xPicalm+/-) significantly aggravates tau pathology: higher pathological tau levels, increased neurofibrillary tangle density, more severe motor deficits, and increased autophagy marker abnormalities compared to Tg30 mice.","method":"Transgenic mouse cross (Tg30 x Picalm+/-), behavioral testing, immunohistochemistry for tau pathology, Western blotting for autophagy markers","journal":"Acta neuropathologica","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic epistasis with tau transgenic model, multiple quantitative readouts (behavior, histology, biochemistry), single lab with rigorous design","pmids":["31925534"],"is_preprint":false},{"year":2003,"finding":"Loss-of-function mutations in the mouse Picalm gene (nonsense/splice-donor mutations causing exon deletions) cause hematopoietic abnormalities, growth retardation, abnormal iron metabolism, and shortened lifespan, establishing PICALM as essential for clathrin-mediated endocytosis-dependent hematopoiesis and iron metabolism in vivo.","method":"ENU mutagenesis screen, Sanger sequencing of Picalm mutant alleles, genetic mapping, molecular characterization of splice variants","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic loss-of-function (multiple alleles) with defined molecular lesions and concordant phenotypes across alleles","pmids":["12832620"],"is_preprint":false},{"year":2021,"finding":"PICALM disruption (CRISPR/Cas9 exon 1 knockout in HeLa cells) increases numbers of early endosomes, increases abundance of lysosomal enzymes in endosome-enriched fractions, disrupts processing and maturation of cathepsin D, and causes autophagy deficits, establishing PICALM as required for correct maturation of lysosomal enzymes.","method":"CRISPR/Cas9 knockout, proteomics of endosome-enriched fractions, Western blotting for cathepsin D processing, immunofluorescence","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with proteomic readout and Western blot validation, single lab, single cell type","pmids":["34311200"],"is_preprint":false},{"year":2015,"finding":"PICALM modulates cellular cholesterol homeostasis: loss of PICALM increases cellular cholesterol pool size (by GC-MS), alters net scavenging of cholesterol, and enhances LDL receptor internalization due to elevated LDLR expression (confirmed by flow cytometry). PICALM influences expression of genes encoding proteins in cholesterol biosynthesis and lipoprotein uptake pathways.","method":"Gene expression studies in PICALM-deficient vs expressing cells, GC-MS cholesterol quantification, isotopic labeling studies, flow cytometry for LDLR internalization","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (transcriptomics, GC-MS, isotopic labeling, flow cytometry), single lab","pmids":["26075887"],"is_preprint":false},{"year":2020,"finding":"In Drosophila, increased expression of the PICALM orthologue lap rescues Aβ42 toxicity (glutamatergic neurotransmission defects, survival, behavioral function) without affecting Aβ42 levels. lap modulates presynaptic vesicular glutamate transporter (VGlut) accumulation and spontaneous glutamate release, and modulates the localization of amphiphysin (BIN1 homologue), which in turn affects postsynaptic glutamate receptor localization.","method":"Drosophila transgenic model, electrophysiology, behavioral assays, confocal imaging of VGlut and GluRII, genetic interaction with Amph/BIN1","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue in Drosophila with electrophysiology and imaging, genetic epistasis with BIN1 homologue, single lab","pmids":["32592479"],"is_preprint":false},{"year":2023,"finding":"Artesunate elevates PICALM mRNA and protein levels in endothelial cells and brain capillaries in vivo. In Picalm+/-;5XFAD mice, artesunate increases capillary PICALM levels, reduces Aβ levels and plaque load, and accelerates Aβ clearance from brain to blood. Endothelial-specific PICALM knockout abolishes all beneficial effects, confirming that endothelial PICALM is required for artesunate's therapeutic effects on Aβ pathology.","method":"FDA-approved drug screen (2007 compounds, luciferase/PICALM promoter assay), endothelial cell mRNA screen, Picalm+/-;5XFAD mice, Picalmlox/lox;Cdh5-Cre;5XFAD mice, Aβ ELISA, behavioral tests, CBF measurements","journal":"Molecular neurodegeneration","confidence":"High","confidence_rationale":"Tier 2 / Strong — endothelial-specific conditional KO abolishes drug effect (epistasis), multiple quantitative in vivo readouts, rigorous genetic controls","pmids":["36707892"],"is_preprint":false},{"year":2020,"finding":"High glucose induces ROS-stimulated Sp1 activation, upregulating PICALM, clathrin heavy chain, and AP2α1, resulting in increased lipid raft-mediated APP endocytosis and early endosomal enlargement that increases Aβ production. PICALM facilitates clathrin-mediated APP endocytosis leading to endosomal enlargement under high glucose conditions.","method":"Human neuroblastoma cells under high glucose, siRNA knockdown of PICALM, ROS inhibition, Sp1 inhibition, diabetic mouse model with pharmacological inhibitors, immunofluorescence, Aβ ELISA","journal":"British journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — mechanistic pathway dissection by siRNA and inhibitors in cell lines with in vivo validation, single lab","pmids":["32436237"],"is_preprint":false},{"year":2025,"finding":"In microglia, the PICALM LOAD-risk allele of rs10792832 reduces PU.1 transcription factor binding and PICALM expression, impairing uptake of Aβ and myelin debris. Reduced PICALM expression in microglia causes lipid droplet (LD) accumulation and phagocytosis deficits. Genetic and pharmacological perturbation established a causal link between reduced PICALM, LD accumulation, and phagocytosis deficits in a microglial-specific manner.","method":"Allele-specific open chromatin mapping in iPSC-derived microglia/neurons/astrocytes, genetic PICALM perturbation, pharmacological perturbation, transcriptomic analysis, lipid droplet quantification, phagocytosis assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — allele-specific chromatin mapping plus genetic and pharmacological perturbations with multiple functional readouts, iPSC-derived human microglia, published in Nature","pmids":["40903578"],"is_preprint":false},{"year":2024,"finding":"PICALM is upregulated in cardiomyocytes during doxorubicin-induced cardiotoxicity and promotes Aβ peptide generation, increasing cardiomyocyte membrane permeability. Genetic depletion and pharmacological blocking peptides targeting PICALM reduce Aβ generation and alleviate doxorubicin-induced cardiotoxicity in vitro and in vivo.","method":"Single cell/nucleus RNA sequencing, doxorubicin mouse model, genetic Picalm depletion, pharmacological blocking peptides, membrane permeability assays, human heart tissue verification","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — single-cell sequencing plus in vivo genetic and pharmacological intervention, human tissue confirmation, single lab","pmids":["38935046"],"is_preprint":false},{"year":2024,"finding":"siRNA-mediated knockdown of Picalm in mature 3T3-L1 adipocytes amplifies insulin-stimulated GLUT4 translocation to the plasma membrane and increases phosphorylation of Akt and Tbc1d4. Picalm depletion before and during differentiation suppresses adipogenesis. Picalm knockdown decreases clathrin-dependent EGF uptake and increases abundance of vesicular trafficking and actin remodeling proteins at the plasma membrane.","method":"siRNA knockdown in 3T3-L1 adipocytes and C2C12 myoblasts, GLUT4 translocation assay, insulin signaling (Akt/Tbc1d4 phosphorylation), EGF internalization assay, plasma membrane proteomics","journal":"Molecular metabolism","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — siRNA KD with multiple functional assays (translocation, signaling, endocytosis, proteomics), single lab","pmids":["39182843"],"is_preprint":false},{"year":2026,"finding":"Picalm depletion in C2C12 myoblasts impairs differentiation through diminished intracellular trafficking dynamics, decreased clathrin-dependent EGF uptake, and increased plasma membrane abundance of vesicular trafficking proteins (Vamp3, Vamp5) and actin remodeling proteins (Actn1, Actn4, Rhog, Rock1, Rock2). Pharmacological stabilization of actin filaments with Jasplakinolide rescues myogenic differentiation in Picalm-deficient cells, establishing a functional link between PICALM-dependent endocytosis, actin remodeling, and myogenesis.","method":"siRNA knockdown in C2C12 myoblasts and primary myocytes, EGF internalization assay, dynamin inhibition (Dyngo-4a), plasma membrane proteomics, Jasplakinolide rescue, autophagy assays","journal":"Molecular metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — phenotypic rescue by actin stabilization provides mechanistic epistasis, multiple orthogonal methods (proteomics, endocytosis assay, pharmacological rescue), single lab","pmids":["41833602"],"is_preprint":false},{"year":2024,"finding":"PICALM knockout by CRISPR-Cas9 screen in CD4+ SupT1 T cells inhibits HIV-1 viral entry and causes defects in intracellular trafficking, increased intracellular Gag accumulation, alterations in autophagy, immune checkpoint PD-1 levels, and differentiation markers, establishing PICALM as a host factor required for HIV-1 entry and intracellular trafficking.","method":"CRISPR-Cas9 screen of 140 membrane trafficking proteins, PICALM KO in SupT1 cells, HIV-1 infection assays, flow cytometry, immunofluorescence","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — CRISPR KO with multiple functional readouts in single lab, identified via unbiased screen","pmids":["38957789"],"is_preprint":false},{"year":2023,"finding":"PICALM localizes to both presynaptic active zones and postsynaptic endocytic zones, co-localizes with APP, and forms nanodomains with distinct morphological properties in different subsynaptic regions. Elevated PICALM expression differentially alters lateral diffusion of APP C-terminal deletion mutants, indicating PICALM regulates APP nanoscale dynamics via the APP C-terminal Y682ENPTY687 domain.","method":"Single-molecule super-resolution imaging (STORM/PALM), single-particle tracking, APP C-terminal deletion mutants, co-localization analysis in neurons","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — super-resolution imaging with domain mutants, single lab, mechanistic link between PICALM and APP nanodomain dynamics","pmids":["37726569"],"is_preprint":false},{"year":2023,"finding":"PICALM knockdown in uninfected cells increases cholesterol in Golgi and TfR-positive recycling endosomes. In Chlamydia-infected cells, PICALM knockdown increases Golgi-derived lipid/protein, TfR, transferrin, and Rab11-FIP1 localized to chlamydial inclusions and decreases Rab11 trafficking to the inclusion, establishing PICALM as a regulator of cholesterol homeostasis and endosomal recycling pathway trafficking to the chlamydial inclusion.","method":"siRNA knockdown of PICALM in infected and uninfected cells, immunofluorescence for cholesterol/Golgi/TfR/Rab11 markers, quantitative imaging","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA knockdown with multiple trafficking readouts, single lab, mechanistic specificity of PICALM in endosomal recycling","pmids":["36779337"],"is_preprint":false},{"year":2021,"finding":"SRSF6 regulates alternative splicing of PICALM exon 14, triggering a switch from short to long PICALM isoform (PICALML). CRNDE lncRNA reduces SRSF6 protein stability, thereby affecting this splicing event. Expression of PICALML contributes to autophagy regulation and chemosensitivity in gastric cancer cells.","method":"RNA splicing analysis, siRNA knockdown of SRSF6, CRNDE overexpression/knockdown, isoform-specific expression analysis, autophagy flux assays","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — mechanistic splicing regulation identified by multiple methods, but focused on lncRNA-mediated regulation rather than PICALM protein mechanism per se","pmids":["33397371"],"is_preprint":false}],"current_model":"PICALM is a clathrin-adaptor protein that drives clathrin-mediated endocytosis by recruiting clathrin and AP2 to the plasma membrane via its phosphatidylinositol (PIP2)-binding domain; it regulates internalization of multiple cargoes including transferrin receptor (controlling iron homeostasis in erythroid cells), APP/LRP1 (controlling Aβ production and BBB transcytosis), and SNARE proteins (VAMP2/3/8), thereby modulating autophagosome formation and lysosomal maturation; in brain endothelium, PICALM links LRP1 and ABCB1/P-gp to guide Aβ transcytosis and clearance, and in microglia the AD-risk allele (rs10792832) reduces PU.1-driven PICALM expression, impairing phagocytosis and causing pathological lipid droplet accumulation."},"narrative":{"mechanistic_narrative":"PICALM is a clathrin-adaptor protein that drives clathrin-mediated endocytosis through its PIP2-binding domain and C-terminal clathrin-association motif, governing the internalization of multiple cell-surface cargoes [PMID:22952941, PMID:25552701]. Its best-defined housekeeping role is in transferrin receptor uptake and iron homeostasis: PICALM loss raises surface TfR, lowers intracellular iron, and impairs erythroid maturation, with the PIP2-binding domain essential for clathrin coat maturation and erythroid development in vivo [PMID:22952941, PMID:22363754, PMID:25552701], consistent with the hematopoietic and iron-metabolism defects of mouse loss-of-function alleles [PMID:12832620]. Beyond endocytosis, PICALM controls autophagy by regulating endocytosis of the SNARE proteins VAMP2/3/8, thereby setting autophagosome formation and degradation and clearance of the autophagy substrate tau [PMID:25241929], and acts within an AP2/PICALM cargo receptor that binds LC3 to route APP-CTF toward autophagic degradation [PMID:24067654]. PICALM also directs maturation of lysosomal enzymes, including cathepsin D processing [PMID:34311200], and shapes cellular cholesterol and LDL-receptor handling [PMID:26075887]. In Alzheimer's-disease-relevant contexts, PICALM binds APP via its NPXY/Y682ENPTY687 motif to control APP internalization, nanoscale dynamics, and Aβ generation [PMID:22539346, PMID:31300465, PMID:37726569], and at the blood-brain barrier it links LRP1 and ABCB1/P-glycoprotein to drive Rab5/Rab11-dependent transcytosis and clearance of Aβ across brain endothelium [PMID:26005850, PMID:30041013]; pharmacological elevation of endothelial PICALM with artesunate reduces Aβ pathology in an endothelial-PICALM-dependent manner [PMID:36707892]. In microglia, an Alzheimer's-risk allele reduces PU.1-driven PICALM expression, impairing phagocytosis of Aβ and myelin debris and causing lipid droplet accumulation [PMID:40903578], while Picalm haploinsufficiency aggravates tau pathology in vivo [PMID:31925534].","teleology":[{"year":2003,"claim":"Established that PICALM is genetically essential in vivo by showing loss-of-function alleles cause hematopoietic, growth, and iron-metabolism defects, framing PICALM as a non-redundant endocytic regulator.","evidence":"ENU mutagenesis screen with molecularly defined Picalm mutant alleles in mice","pmids":["12832620"],"confidence":"High","gaps":["Did not identify the specific cargo or molecular step disrupted","Mechanism linking endocytosis defect to phenotype not resolved"]},{"year":2012,"claim":"Defined the molecular cargo behind the iron phenotype, showing PICALM drives clathrin-mediated transferrin receptor endocytosis required for erythroid maturation.","evidence":"PICALM-deficient/KO mice and MEFs with retroviral rescue, C-terminal deletion mutants, transferrin endocytosis and iron assays","pmids":["22952941","22363754"],"confidence":"High","gaps":["C-terminal clathrin-binding region mapped but structural basis not resolved","Did not address non-erythroid cargoes"]},{"year":2014,"claim":"Demonstrated the PIP2-binding domain is the essential functional element for TfR endocytosis and erythroid development and required for clathrin coat maturation.","evidence":"Conditional Picalm KO mice with PIP2-domain mutant, freeze-etch EM, Jak2(V617F) polycythemia vera rescue","pmids":["25552701"],"confidence":"High","gaps":["Cell-type specificity of cargo selection not fully explained","Structural mechanism of coat maturation incomplete"]},{"year":2014,"claim":"Extended PICALM beyond cargo uptake to autophagy regulation by identifying SNARE proteins (VAMP2/3/8) as endocytic substrates affecting distinct autophagy stages.","evidence":"siRNA/overexpression in cell lines plus zebrafish transgenic tau-clearance models","pmids":["25241929"],"confidence":"High","gaps":["Direct interaction interface with each VAMP not defined","Stage-specific contribution of each SNARE not separated"]},{"year":2013,"claim":"Showed PICALM acts in an AP2-containing autophagic cargo receptor that bridges LC3 and APP-CTF, providing a molecular route from endocytosis to autophagic degradation.","evidence":"Affinity purification/MS, co-IP, siRNA knockdown, live imaging","pmids":["24067654"],"confidence":"High","gaps":["Stoichiometry and direct LC3-binding determinant on PICALM vs AP2 not resolved","In vivo relevance not tested here"]},{"year":2012,"claim":"Connected PICALM to amyloid biology by showing it controls APP internalization and bidirectionally sets Aβ production in cells and APP/PS1 mice.","evidence":"siRNA/overexpression in N2a-APP cells, AAV8 shRNA/cDNA in APP/PS1 mice, colocalization and ELISA","pmids":["22539346"],"confidence":"High","gaps":["Did not define the APP-PICALM binding determinant","Did not distinguish neuronal vs vascular contributions"]},{"year":2015,"claim":"Identified PICALM as a blood-brain-barrier clearance factor that internalizes LRP1-bound Aβ through Rab5/Rab11 endosomes for transcytosis.","evidence":"Human and iPSC endothelial monolayers, Picalm-deficient mice with adenoviral rescue, live imaging","pmids":["26005850"],"confidence":"High","gaps":["Did not identify all endothelial partners coordinating transcytosis","Directionality control of transcytosis not fully resolved"]},{"year":2013,"claim":"Linked PICALM to tau pathology, showing PICALM is proteolytically cleaved and depleted in AD brain and associates with PHF-tau.","evidence":"Western blot, in vitro calpain/caspase cleavage assay, IHC, co-IP from AD brain","pmids":["23589030"],"confidence":"Medium","gaps":["Co-IP without reciprocal validation; directness of PICALM-tau interaction unclear","Functional consequence of cleavage not established"]},{"year":2015,"claim":"Broadened PICALM's lipid trafficking role to cholesterol homeostasis and LDL-receptor handling.","evidence":"Transcriptomics, GC-MS cholesterol quantification, isotopic labeling, flow cytometry for LDLR internalization","pmids":["26075887"],"confidence":"Medium","gaps":["Mechanism by which PICALM alters cholesterol-gene expression unknown","Single lab, single cell context"]},{"year":2018,"claim":"Provided the endothelial protein-interaction basis for Aβ clearance, showing PICALM physically links LRP1 and ABCB1/P-gp.","evidence":"Co-IP, co-immunostaining, dual ABCB1/LRP1 inhibition in brain endothelium","pmids":["30041013"],"confidence":"Medium","gaps":["Co-IP/co-staining without direct binding-site mapping","Whether interaction is direct or scaffolded not resolved"]},{"year":2019,"claim":"Defined the APP-PICALM interaction at the NPXY motif and showed PTB-domain adaptors (Numb, JIP1b, GULP1) tune the interaction, surface APP, and PICALM nuclear shuttling.","evidence":"Co-IP with APP NPXY mutation, FACS, internalization assays, fluorescence microscopy","pmids":["31300465"],"confidence":"Medium","gaps":["Functional consequence of PICALM nuclear shuttling unknown","Single lab without in vivo confirmation"]},{"year":2020,"claim":"Established genetic epistasis with tau pathology, showing Picalm haploinsufficiency aggravates tau accumulation and motor deficits in vivo.","evidence":"Tg30 x Picalm+/- mouse cross, behavior, IHC, autophagy-marker Western blots","pmids":["31925534"],"confidence":"High","gaps":["Did not separate autophagy from endocytic contributions to tau handling","Cell-type origin of effect not dissected"]},{"year":2020,"claim":"Positioned PICALM as a convergence node for AD risk by showing its overexpression rescues APOE4-induced endocytic defects across yeast and human astrocytes.","evidence":"Isogenic APOE3/APOE4 iPSC astrocytes and yeast Yap1802p rescue, endocytosis assays","pmids":["33027662"],"confidence":"Medium","gaps":["Molecular target of the APOE4 endocytic defect not identified","Astrocyte-specific consequences in vivo untested"]},{"year":2021,"claim":"Showed PICALM is required for lysosomal enzyme maturation, linking it to endosome-to-lysosome processing and autophagy.","evidence":"CRISPR/Cas9 PICALM KO in HeLa, proteomics of endosome fractions, cathepsin D Western blot","pmids":["34311200"],"confidence":"Medium","gaps":["Mechanism connecting endocytic defect to cathepsin D mis-processing unclear","Single cell type"]},{"year":2023,"claim":"Resolved PICALM's subsynaptic organization, showing it forms nanodomains at pre- and postsynaptic zones and controls APP nanoscale dynamics via the APP C-terminal motif.","evidence":"STORM/PALM super-resolution imaging, single-particle tracking, APP C-terminal mutants in neurons","pmids":["37726569"],"confidence":"Medium","gaps":["Functional readout of altered APP diffusion not measured","Single lab"]},{"year":2023,"claim":"Provided in vivo therapeutic proof-of-concept that elevating endothelial PICALM clears Aβ, with the effect strictly dependent on endothelial PICALM.","evidence":"FDA drug screen identifying artesunate, Picalm+/-;5XFAD and endothelial conditional KO mice, Aβ ELISA, CBF","pmids":["36707892"],"confidence":"High","gaps":["Mechanism by which artesunate raises PICALM transcription incompletely defined","Long-term safety/efficacy not addressed"]},{"year":2025,"claim":"Connected the AD-risk variant to microglial dysfunction, showing rs10792832 reduces PU.1-driven PICALM expression, impairing phagocytosis and causing lipid droplet accumulation.","evidence":"Allele-specific open-chromatin mapping in iPSC microglia/neurons/astrocytes, genetic and pharmacological perturbation, phagocytosis and lipid droplet assays","pmids":["40903578"],"confidence":"High","gaps":["How reduced endocytosis mechanistically drives lipid droplet buildup not fully resolved","Other risk-allele effects on non-microglial cells not addressed"]},{"year":2024,"claim":"Extended PICALM's functional reach to peripheral systems, implicating it in HIV-1 entry, doxorubicin cardiotoxicity, and adipocyte insulin/GLUT4 signaling.","evidence":"CRISPR screen in CD4+ T cells; scRNA-seq plus Picalm depletion in doxorubicin cardiotoxicity; siRNA in 3T3-L1 adipocytes with GLUT4 and insulin-signaling assays","pmids":["38957789","38935046","39182843"],"confidence":"Medium","gaps":["Whether these reflect a single shared endocytic mechanism unclear","Direct molecular partners in each context not mapped"]},{"year":2026,"claim":"Tied PICALM-dependent endocytosis to actin remodeling and myogenesis by showing actin stabilization rescues differentiation in PICALM-deficient myoblasts.","evidence":"siRNA in C2C12/primary myocytes, EGF internalization, plasma membrane proteomics, Jasplakinolide rescue","pmids":["41833602"],"confidence":"Medium","gaps":["Direct physical link between PICALM and actin machinery not demonstrated","Single lab"]},{"year":null,"claim":"How PICALM selects among its diverse cargoes (TfR, APP, SNAREs, LDLR, GLUT4) in a cell-type-specific manner, and the structural determinants distinguishing these interactions, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model of cargo selectivity","Isoform-specific functions (e.g., PICALML) largely uncharacterized","Mechanism coupling PICALM endocytosis to autophagy and lysosomal maturation not fully defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,5,7]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[7,15]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,7,18,24]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[0,14,25]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3,2]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[5,6,7,9]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[1,2,14]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,3,12,19]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,8]}],"complexes":["AP2/PICALM clathrin adaptor complex"],"partners":["AP2","LRP1","ABCB1","APP","VAMP2","VAMP3","VAMP8","LC3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13492","full_name":"Phosphatidylinositol-binding clathrin assembly protein","aliases":["Clathrin assembly lymphoid myeloid leukemia protein"],"length_aa":652,"mass_kda":70.8,"function":"Cytoplasmic adapter protein that plays a critical role in clathrin-mediated endocytosis which is important in processes such as internalization of cell receptors, synaptic transmission or removal of apoptotic cells. Recruits AP-2 and attaches clathrin triskelions to the cytoplasmic side of plasma membrane leading to clathrin-coated vesicles (CCVs) assembly (PubMed:10436022, PubMed:16262731, PubMed:27574975). Furthermore, regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature (PubMed:25898166). In addition to binding to clathrin, mediates the endocytosis of small R-SNARES (Soluble NSF Attachment Protein REceptors) between plasma membranes and endosomes including VAMP2, VAMP3, VAMP4, VAMP7 or VAMP8 (PubMed:21808019, PubMed:22118466, PubMed:23741335). In turn, PICALM-dependent SNARE endocytosis is required for the formation and maturation of autophagic precursors (PubMed:25241929). Modulates thereby autophagy and the turnover of autophagy substrates such as MAPT/TAU or amyloid precursor protein cleaved C-terminal fragment (APP-CTF) (PubMed:24067654, PubMed:25241929)","subcellular_location":"Cell membrane; Membrane, clathrin-coated pit; Golgi apparatus; Cytoplasmic vesicle, clathrin-coated vesicle; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13492/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PICALM","classification":"Not Classified","n_dependent_lines":59,"n_total_lines":1208,"dependency_fraction":0.048841059602649006},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000073921","cell_line_id":"CID000543","localizations":[{"compartment":"membrane","grade":3}],"interactors":[{"gene":"OSTC","stoichiometry":10.0},{"gene":"DAD1","stoichiometry":4.0},{"gene":"DDOST","stoichiometry":4.0},{"gene":"ARHGAP18","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"CLTA","stoichiometry":0.2},{"gene":"CLTB","stoichiometry":0.2},{"gene":"HNRNPA2B1","stoichiometry":0.2},{"gene":"KRTCAP2","stoichiometry":0.2},{"gene":"OST4","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000543","total_profiled":1310},"omim":[{"mim_id":"620961","title":"SORTING NEXIN 25; SNX25","url":"https://www.omim.org/entry/620961"},{"mim_id":"617611","title":"PICALM-INTERACTING MITOTIC REGULATOR; PIMREG","url":"https://www.omim.org/entry/617611"},{"mim_id":"616916","title":"SMALL ADP-RIBOSYLATION FACTOR GTPase-ACTIVATING PROTEIN 2; SMAP2","url":"https://www.omim.org/entry/616916"},{"mim_id":"603025","title":"PHOSPHATIDYLINOSITOL-BINDING CLATHRIN ASSEMBLY PROTEIN; PICALM","url":"https://www.omim.org/entry/603025"},{"mim_id":"104310","title":"ALZHEIMER DISEASE 2; AD2","url":"https://www.omim.org/entry/104310"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Vesicles","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PICALM"},"hgnc":{"alias_symbol":["CALM","CLTH"],"prev_symbol":[]},"alphafold":{"accession":"Q13492","domains":[{"cath_id":"1.25.40.90","chopping":"5-336","consensus_level":"medium","plddt":91.3287,"start":5,"end":336}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13492","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13492-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13492-F1-predicted_aligned_error_v6.png","plddt_mean":66.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PICALM","jax_strain_url":"https://www.jax.org/strain/search?query=PICALM"},"sequence":{"accession":"Q13492","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13492.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13492/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13492"}},"corpus_meta":[{"pmid":"26005850","id":"PMC_26005850","title":"Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance.","date":"2015","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26005850","citation_count":356,"is_preprint":false},{"pmid":"25241929","id":"PMC_25241929","title":"PICALM modulates autophagy activity and tau accumulation.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25241929","citation_count":221,"is_preprint":false},{"pmid":"24067654","id":"PMC_24067654","title":"Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24067654","citation_count":201,"is_preprint":false},{"pmid":"20554627","id":"PMC_20554627","title":"Replication of CLU, CR1, and PICALM associations with alzheimer disease.","date":"2010","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20554627","citation_count":178,"is_preprint":false},{"pmid":"33397371","id":"PMC_33397371","title":"LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM.","date":"2021","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33397371","citation_count":156,"is_preprint":false},{"pmid":"22539346","id":"PMC_22539346","title":"Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22539346","citation_count":132,"is_preprint":false},{"pmid":"23589030","id":"PMC_23589030","title":"Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.","date":"2013","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/23589030","citation_count":118,"is_preprint":false},{"pmid":"30041013","id":"PMC_30041013","title":"The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.","date":"2018","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30041013","citation_count":117,"is_preprint":false},{"pmid":"25186232","id":"PMC_25186232","title":"The Role of PICALM in Alzheimer's Disease.","date":"2014","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/25186232","citation_count":93,"is_preprint":false},{"pmid":"20838239","id":"PMC_20838239","title":"Distribution and expression of picalm in Alzheimer disease.","date":"2010","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20838239","citation_count":93,"is_preprint":false},{"pmid":"36552756","id":"PMC_36552756","title":"PICALM and Alzheimer's Disease: An Update and Perspectives.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36552756","citation_count":84,"is_preprint":false},{"pmid":"23572399","id":"PMC_23572399","title":"PICALM gene rs3851179 polymorphism contributes to Alzheimer's disease in an Asian population.","date":"2013","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23572399","citation_count":83,"is_preprint":false},{"pmid":"33027662","id":"PMC_33027662","title":"PICALM Rescues Endocytic Defects Caused by the Alzheimer's Disease Risk Factor APOE4.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33027662","citation_count":73,"is_preprint":false},{"pmid":"22888099","id":"PMC_22888099","title":"A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity.","date":"2012","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/22888099","citation_count":69,"is_preprint":false},{"pmid":"24618820","id":"PMC_24618820","title":"Genetics of PICALM expression and Alzheimer's disease.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24618820","citation_count":61,"is_preprint":false},{"pmid":"20570404","id":"PMC_20570404","title":"Association of CLU and PICALM variants with Alzheimer's disease.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/20570404","citation_count":61,"is_preprint":false},{"pmid":"20739100","id":"PMC_20739100","title":"Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest old.","date":"2010","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/20739100","citation_count":57,"is_preprint":false},{"pmid":"27048444","id":"PMC_27048444","title":"PICALM rs3851179 Variant Confers Susceptibility to Alzheimer's Disease in Chinese Population.","date":"2016","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27048444","citation_count":55,"is_preprint":false},{"pmid":"27260836","id":"PMC_27260836","title":"Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.","date":"2016","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/27260836","citation_count":55,"is_preprint":false},{"pmid":"22952941","id":"PMC_22952941","title":"The PICALM protein plays a key role in iron homeostasis and cell proliferation.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22952941","citation_count":54,"is_preprint":false},{"pmid":"24643340","id":"PMC_24643340","title":"Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial.","date":"2014","source":"Genes & nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/24643340","citation_count":51,"is_preprint":false},{"pmid":"12832620","id":"PMC_12832620","title":"Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12832620","citation_count":51,"is_preprint":false},{"pmid":"27430330","id":"PMC_27430330","title":"Decreasing the expression of PICALM reduces endocytosis and the activity of β-secretase: implications for Alzheimer's disease.","date":"2016","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27430330","citation_count":48,"is_preprint":false},{"pmid":"22363754","id":"PMC_22363754","title":"The clathrin assembly protein PICALM is required for erythroid maturation and transferrin internalization in mice.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22363754","citation_count":48,"is_preprint":false},{"pmid":"22871473","id":"PMC_22871473","title":"PICALM-MLLT10 acute myeloid leukemia: a French cohort of 18 patients.","date":"2012","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/22871473","citation_count":45,"is_preprint":false},{"pmid":"24660791","id":"PMC_24660791","title":"The benefits of staying active in old age: physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning.","date":"2014","source":"Psychology and aging","url":"https://pubmed.ncbi.nlm.nih.gov/24660791","citation_count":40,"is_preprint":false},{"pmid":"31925534","id":"PMC_31925534","title":"Picalm reduction exacerbates tau pathology in a murine tauopathy model.","date":"2020","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/31925534","citation_count":38,"is_preprint":false},{"pmid":"25552701","id":"PMC_25552701","title":"Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiology.","date":"2014","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/25552701","citation_count":37,"is_preprint":false},{"pmid":"20951388","id":"PMC_20951388","title":"Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese.","date":"2010","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20951388","citation_count":37,"is_preprint":false},{"pmid":"26611835","id":"PMC_26611835","title":"Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1.","date":"2015","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26611835","citation_count":35,"is_preprint":false},{"pmid":"32991610","id":"PMC_32991610","title":"Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32991610","citation_count":35,"is_preprint":false},{"pmid":"22402018","id":"PMC_22402018","title":"Implication of common and disease specific variants in CLU, CR1, and PICALM.","date":"2012","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/22402018","citation_count":33,"is_preprint":false},{"pmid":"20674675","id":"PMC_20674675","title":"APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20674675","citation_count":26,"is_preprint":false},{"pmid":"21466683","id":"PMC_21466683","title":"CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques.","date":"2011","source":"Alzheimer's research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21466683","citation_count":25,"is_preprint":false},{"pmid":"36707892","id":"PMC_36707892","title":"Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.","date":"2023","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/36707892","citation_count":24,"is_preprint":false},{"pmid":"20875875","id":"PMC_20875875","title":"Acute leukemia with PICALM-MLLT10 fusion gene: diagnostic and treatment struggle.","date":"2010","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20875875","citation_count":23,"is_preprint":false},{"pmid":"25022885","id":"PMC_25022885","title":"Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.","date":"2014","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/25022885","citation_count":23,"is_preprint":false},{"pmid":"28549650","id":"PMC_28549650","title":"Effect of PICALM rs3851179 polymorphism on the default mode network function in mild cognitive impairment.","date":"2017","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/28549650","citation_count":22,"is_preprint":false},{"pmid":"28567584","id":"PMC_28567584","title":"rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population.","date":"2017","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28567584","citation_count":21,"is_preprint":false},{"pmid":"31853228","id":"PMC_31853228","title":"Exosomal MicroRNA-155 Inhibits Enterovirus A71 Infection by Targeting PICALM.","date":"2019","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31853228","citation_count":20,"is_preprint":false},{"pmid":"40903578","id":"PMC_40903578","title":"PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/40903578","citation_count":19,"is_preprint":false},{"pmid":"32436237","id":"PMC_32436237","title":"High glucose-mediated PICALM and mTORC1 modulate processing of amyloid precursor protein via endosomal abnormalities.","date":"2020","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32436237","citation_count":19,"is_preprint":false},{"pmid":"24095218","id":"PMC_24095218","title":"Genetic variation in PICALM and Alzheimer's disease risk in Han Chinese.","date":"2013","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/24095218","citation_count":19,"is_preprint":false},{"pmid":"33386803","id":"PMC_33386803","title":"PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression.","date":"2021","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/33386803","citation_count":18,"is_preprint":false},{"pmid":"23650005","id":"PMC_23650005","title":"Lack of association of CR1, PICALM and CLU gene polymorphisms with Alzheimer disease in a Polish population.","date":"2013","source":"Neurologia i neurochirurgia polska","url":"https://pubmed.ncbi.nlm.nih.gov/23650005","citation_count":18,"is_preprint":false},{"pmid":"28631188","id":"PMC_28631188","title":"Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28631188","citation_count":17,"is_preprint":false},{"pmid":"28357335","id":"PMC_28357335","title":"Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs.","date":"2016","source":"Microbial cell (Graz, Austria)","url":"https://pubmed.ncbi.nlm.nih.gov/28357335","citation_count":17,"is_preprint":false},{"pmid":"30040717","id":"PMC_30040717","title":"PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.","date":"2018","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/30040717","citation_count":16,"is_preprint":false},{"pmid":"31133980","id":"PMC_31133980","title":"Genetic Variants of PICALM rs541458 Modulate Brain Spontaneous Activity in Older Adults With Amnestic Mild Cognitive Impairment.","date":"2019","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31133980","citation_count":16,"is_preprint":false},{"pmid":"22943764","id":"PMC_22943764","title":"Identification and confirmation of an exonic splicing enhancer variation in exon 5 of the Alzheimer disease associated PICALM gene.","date":"2012","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22943764","citation_count":16,"is_preprint":false},{"pmid":"25169757","id":"PMC_25169757","title":"An intronic PICALM polymorphism, rs588076, is associated with allelic expression of a PICALM isoform.","date":"2014","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/25169757","citation_count":15,"is_preprint":false},{"pmid":"31300465","id":"PMC_31300465","title":"The role of PTB domain containing adaptor proteins on PICALM-mediated APP endocytosis and localization.","date":"2019","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/31300465","citation_count":15,"is_preprint":false},{"pmid":"28558900","id":"PMC_28558900","title":"Effect of CLU and PICALM polymorphisms on AD risk: A study from south India.","date":"2016","source":"Asian journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/28558900","citation_count":15,"is_preprint":false},{"pmid":"24898977","id":"PMC_24898977","title":"A single codon insertion in PICALM is associated with development of familial subvalvular aortic stenosis in Newfoundland dogs.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24898977","citation_count":14,"is_preprint":false},{"pmid":"21297266","id":"PMC_21297266","title":"Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians.","date":"2011","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/21297266","citation_count":14,"is_preprint":false},{"pmid":"26075887","id":"PMC_26075887","title":"Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26075887","citation_count":13,"is_preprint":false},{"pmid":"33170153","id":"PMC_33170153","title":"Association of Alzheimer's disease risk variants on the PICALM gene with PICALM expression, core biomarkers, and feature neurodegeneration.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33170153","citation_count":13,"is_preprint":false},{"pmid":"32592479","id":"PMC_32592479","title":"PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Aβ42 toxicity.","date":"2020","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32592479","citation_count":13,"is_preprint":false},{"pmid":"27117083","id":"PMC_27117083","title":"The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27117083","citation_count":13,"is_preprint":false},{"pmid":"28073596","id":"PMC_28073596","title":"Quantitative EEG during normal aging: association with the Alzheimer's disease genetic risk variant in PICALM gene.","date":"2016","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28073596","citation_count":13,"is_preprint":false},{"pmid":"29480189","id":"PMC_29480189","title":"A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.","date":"2018","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/29480189","citation_count":13,"is_preprint":false},{"pmid":"35501863","id":"PMC_35501863","title":"PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway.","date":"2022","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/35501863","citation_count":12,"is_preprint":false},{"pmid":"28316001","id":"PMC_28316001","title":"Associations of polymorphisms in the candidate genes for Alzheimer's disease BIN1, CLU, CR1 and PICALM with gestational diabetes and impaired glucose tolerance.","date":"2017","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28316001","citation_count":11,"is_preprint":false},{"pmid":"31385771","id":"PMC_31385771","title":"Association of PICALM Gene Polymorphisms with Alzheimer's Disease: Evidence from an Updated Meta-Analysis.","date":"2019","source":"Current Alzheimer research","url":"https://pubmed.ncbi.nlm.nih.gov/31385771","citation_count":10,"is_preprint":false},{"pmid":"37743097","id":"PMC_37743097","title":"Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.","date":"2023","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/37743097","citation_count":10,"is_preprint":false},{"pmid":"34311200","id":"PMC_34311200","title":"PICALM regulates cathepsin D processing and lysosomal function.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/34311200","citation_count":10,"is_preprint":false},{"pmid":"30227397","id":"PMC_30227397","title":"Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.","date":"2018","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/30227397","citation_count":9,"is_preprint":false},{"pmid":"38826437","id":"PMC_38826437","title":"Alzheimer's disease risk allele of PICALM causes detrimental lipid droplets in microglia.","date":"2024","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/38826437","citation_count":8,"is_preprint":false},{"pmid":"32372909","id":"PMC_32372909","title":"Genetic Association Between Alzheimer's Disease Risk Variant of the PICALM Gene and EEG Functional Connectivity in Non-demented Adults.","date":"2020","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32372909","citation_count":8,"is_preprint":false},{"pmid":"31739126","id":"PMC_31739126","title":"Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.","date":"2019","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31739126","citation_count":7,"is_preprint":false},{"pmid":"22715855","id":"PMC_22715855","title":"Lack of association of the PICALM rs3851179 polymorphism with Parkinson's disease in the Greek population.","date":"2012","source":"The International journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22715855","citation_count":7,"is_preprint":false},{"pmid":"38971327","id":"PMC_38971327","title":"Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion.","date":"2024","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/38971327","citation_count":6,"is_preprint":false},{"pmid":"36552141","id":"PMC_36552141","title":"PICALM rs3851179 Variants Modulate Left Postcentral Cortex Thickness, CSF Amyloid β42, and Phosphorylated Tau in the Elderly.","date":"2022","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36552141","citation_count":6,"is_preprint":false},{"pmid":"38895061","id":"PMC_38895061","title":"PICALM::MLLT10 may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclax.","date":"2024","source":"EJHaem","url":"https://pubmed.ncbi.nlm.nih.gov/38895061","citation_count":6,"is_preprint":false},{"pmid":"38935046","id":"PMC_38935046","title":"PICALM Regulating the Generation of Amyloid β-Peptide to Promote Anthracycline-Induced Cardiotoxicity.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/38935046","citation_count":5,"is_preprint":false},{"pmid":"39182843","id":"PMC_39182843","title":"Picalm, a novel regulator of GLUT4-trafficking in adipose tissue.","date":"2024","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39182843","citation_count":5,"is_preprint":false},{"pmid":"38237377","id":"PMC_38237377","title":"miR-155-5p promotes hepatic steatosis via PICALM-mediated autophagy in aging hepatocytes.","date":"2024","source":"Archives of gerontology and geriatrics","url":"https://pubmed.ncbi.nlm.nih.gov/38237377","citation_count":5,"is_preprint":false},{"pmid":"38957789","id":"PMC_38957789","title":"An HIV-1 CRISPR-Cas9 membrane trafficking screen reveals a role for PICALM intersecting endolysosomes and immunity.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38957789","citation_count":5,"is_preprint":false},{"pmid":"16518848","id":"PMC_16518848","title":"Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.","date":"2006","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16518848","citation_count":5,"is_preprint":false},{"pmid":"26434199","id":"PMC_26434199","title":"LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.","date":"2015","source":"Ideggyogyaszati szemle","url":"https://pubmed.ncbi.nlm.nih.gov/26434199","citation_count":4,"is_preprint":false},{"pmid":"30472946","id":"PMC_30472946","title":"Genetic Association between Alzheimer's Disease Risk Variant of the PICALM Gene and Auditory Event-Related Potentials in Aging.","date":"2018","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/30472946","citation_count":4,"is_preprint":false},{"pmid":"39499083","id":"PMC_39499083","title":"PICALM-MLLT10 fusion gene in hematological neoplasms: clinical features, current practices, and prognoses.","date":"2024","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/39499083","citation_count":3,"is_preprint":false},{"pmid":"39822730","id":"PMC_39822730","title":"Cholangiocyte-derived exosomal long noncoding RNA PICALM-AU1 promotes pulmonary endothelial cell endothelial-mesenchymal transition in hepatopulmonary syndrome.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39822730","citation_count":3,"is_preprint":false},{"pmid":"37726569","id":"PMC_37726569","title":"Real-time heterogeneity of supramolecular assembly of amyloid precursor protein is modulated by an endocytic risk factor PICALM.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/37726569","citation_count":3,"is_preprint":false},{"pmid":"38363532","id":"PMC_38363532","title":"The Effects of PICALM rs3851179 and Age on Brain Atrophy and Cognition Along the Alzheimer's Disease Continuum.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/38363532","citation_count":2,"is_preprint":false},{"pmid":"36779337","id":"PMC_36779337","title":"Eukaryotic Clathrin Adapter Protein and Mediator of Cholesterol Homeostasis, PICALM, Affects Trafficking to the Chlamydial Inclusion.","date":"2023","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/36779337","citation_count":2,"is_preprint":false},{"pmid":"23954523","id":"PMC_23954523","title":"Mass spectrometry quantification of PICALM and AP180 in human frontal cortex and neural retina.","date":"2013","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23954523","citation_count":2,"is_preprint":false},{"pmid":"35864751","id":"PMC_35864751","title":"Genetic Predictors of Change in Episodic Verbal Memory by Cognitive Intervention: ACT, PICALM, BDNF, NRG1, APOE Genes and Their Interactions in Situations of Cognitive Demand.","date":"2022","source":"Journal of integrative neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35864751","citation_count":2,"is_preprint":false},{"pmid":"30039188","id":"PMC_30039188","title":"Correlation of PICALM polymorphism rs3851179 with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review.","date":"2018","source":"Metabolic brain disease","url":"https://pubmed.ncbi.nlm.nih.gov/30039188","citation_count":1,"is_preprint":false},{"pmid":"38007652","id":"PMC_38007652","title":"PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.","date":"2023","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/38007652","citation_count":1,"is_preprint":false},{"pmid":"40272654","id":"PMC_40272654","title":"MiR- 142 - 3p Up-regulation Mitigates Cerebral Ischemia-reperfusion Injury by Targeting PICALM.","date":"2025","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/40272654","citation_count":1,"is_preprint":false},{"pmid":"37171905","id":"PMC_37171905","title":"An unusual presentation of a pediatric patient with mixed phenotypic acute leukemia with PICALM::MLLT10 gene rearrangement.","date":"2023","source":"Pediatric hematology and oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37171905","citation_count":1,"is_preprint":false},{"pmid":"26972434","id":"PMC_26972434","title":"Re: \"PICALM Gene rs3851179 Polymorphism Contributes to Alzheimer's Disease in an Asian Population\".","date":"2016","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26972434","citation_count":1,"is_preprint":false},{"pmid":"41532548","id":"PMC_41532548","title":"PICALM::MLLT10 translocated leukemia.","date":"2026","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/41532548","citation_count":0,"is_preprint":false},{"pmid":"41833602","id":"PMC_41833602","title":"Picalm coordinates clathrin-mediated endocytosis and actin remodeling during myogenesis.","date":"2026","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/41833602","citation_count":0,"is_preprint":false},{"pmid":"41677602","id":"PMC_41677602","title":"PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer's Disease.","date":"2026","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/41677602","citation_count":0,"is_preprint":false},{"pmid":"40983660","id":"PMC_40983660","title":"Observation of PICALM::MLLT10-rearrangement and coincidental EZH2 mutations in a patient with acute myeloid leukemia: A case report and review of the literature.","date":"2025","source":"BJC reports","url":"https://pubmed.ncbi.nlm.nih.gov/40983660","citation_count":0,"is_preprint":false},{"pmid":"40050091","id":"PMC_40050091","title":"[Diagnostic PICALM::MLLT10 fusion by transcriptome sequencing in acute myeloid leukemia and its clinical characteristics].","date":"2025","source":"Zhonghua nei ke za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/40050091","citation_count":0,"is_preprint":false},{"pmid":"42250393","id":"PMC_42250393","title":"Microglial PICALM: A novel genetic driver and therapeutic target in vascular dementia.","date":"2026","source":"Archives of gerontology and geriatrics","url":"https://pubmed.ncbi.nlm.nih.gov/42250393","citation_count":0,"is_preprint":false},{"pmid":"41565572","id":"PMC_41565572","title":"Precursor B-Cell Acute Lymphoblastic Leukemia With PICALM∶∶MLLT10 Fusion Gene Positivity:Report of One Case and Literature Review.","date":"2026","source":"Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae","url":"https://pubmed.ncbi.nlm.nih.gov/41565572","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50460,"output_tokens":7402,"usd":0.131205,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16633,"output_tokens":5582,"usd":0.111357,"stage2_stop_reason":"end_turn"},"total_usd":0.242562,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"PICALM regulates clathrin-dependent internalization of Aβ bound to LRP1 at the blood-brain barrier and guides Aβ trafficking through Rab5 and Rab11 endosomal compartments, leading to transcytosis and clearance of Aβ across brain endothelium. Endothelial PICALM deficiency diminishes Aβ clearance and accelerates Aβ pathology, reversible by endothelial PICALM re-expression.\",\n      \"method\": \"Human brain endothelial monolayers, Picalm-deficient mice, adenoviral PICALM re-expression, iPSC-derived endothelial cells, live imaging, immunofluorescence\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vivo mouse KD, human endothelial monolayers, iPSC cells, adenoviral rescue), replicated across cell and animal models in single rigorous study\",\n      \"pmids\": [\"26005850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PICALM/CALM modulates autophagy by regulating the endocytosis of SNARE proteins VAMP2, VAMP3, and VAMP8, which affect distinct stages of autophagy from autophagosome formation to degradation. CALM overexpression or depletion alters tau clearance (an autophagy substrate) both in vitro and in vivo in zebrafish transgenic models.\",\n      \"method\": \"siRNA knockdown, overexpression in cell lines, zebrafish transgenic models, endocytosis assays for SNARE proteins\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (in vitro knockdown/OE plus in vivo zebrafish model), identified specific SNARE substrates mechanistically linking PICALM to autophagy stages\",\n      \"pmids\": [\"25241929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PICALM forms a complex with adaptor protein AP2 that functions as an autophagic cargo receptor; AP2/PICALM binds LC3 (identified by affinity purification/mass spectrometry) and cross-links LC3 with APP-CTF, directing APP-CTF from the endocytic pathway to autophagic degradation. AP2 knockdown reduces autophagy-mediated APP-CTF degradation.\",\n      \"method\": \"Affinity purification followed by mass spectrometry, co-immunoprecipitation, siRNA knockdown, live imaging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — AP/MS identification confirmed by co-IP and live imaging, multiple orthogonal methods in single study\",\n      \"pmids\": [\"24067654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PICALM co-localizes with APP in intracellular vesicles after endocytosis. PICALM knockdown reduces APP internalization and Aβ generation; PICALM overexpression increases APP internalization and Aβ production. In vivo AAV-mediated PICALM manipulation in APP/PS1 mice bidirectionally alters soluble and insoluble Aβ levels and amyloid plaque load.\",\n      \"method\": \"siRNA knockdown, PICALM overexpression in N2a-APP cells, AAV8 gene transfer (shRNA and cDNA) in APP/PS1 mice, colocalization imaging, ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional manipulation (KD and OE) in cell and in vivo mouse models with quantitative Aβ readouts\",\n      \"pmids\": [\"22539346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PICALM is abnormally cleaved in AD brains by calpain or caspase (demonstrated in vitro); full-length PICALM is decreased in AD. PICALM co-localizes with neurofibrillary tangles containing conformationally abnormal hyperphosphorylated tau, and PHF-tau proteins co-immunoprecipitate with PICALM.\",\n      \"method\": \"Western blotting with anti-PICALM antibodies, in vitro calpain/caspase activation assay, immunohistochemistry, co-immunoprecipitation\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — co-IP and in vitro cleavage assay plus IHC, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"23589030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PICALM plays a critical role in transferrin receptor (TfR) internalization and iron homeostasis. PICALM-deficient MEFs show increased surface TfR expression, decreased intracellular iron, and reduced proliferation, all rescued by retroviral PICALM re-expression. C-terminal PICALM residues are critical for clathrin association and inhibitory effect on TfR internalization.\",\n      \"method\": \"PICALM overexpression and knockdown/deficient MEFs from fit1 mice, retroviral rescue, flow cytometry, iron supplementation experiments, C-terminal deletion mutants\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — bidirectional manipulation with retroviral rescue, domain mutagenesis, multiple orthogonal readouts in single study\",\n      \"pmids\": [\"22952941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CALM/PICALM is required for clathrin-mediated endocytosis of transferrin and for erythroid maturation in mice. CALM-deficient mice exhibit severe anemia and impaired iron content in erythroid precursors; CALM-deficient erythroid cells and embryonic fibroblasts show impaired clathrin-mediated transferrin endocytosis.\",\n      \"method\": \"CALM-deficient mouse model, transferrin endocytosis assays in erythroid cells and embryonic fibroblasts, histological analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout mouse model with specific cellular endocytosis readouts, replicates findings from parallel study (PMID:22952941)\",\n      \"pmids\": [\"22363754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PICALM PIP2-binding domain is necessary for transferrin receptor endocytosis in erythroblasts and absolutely essential for erythroid development. PICALM functions as a cell-type-specific regulator of transferrin receptor endocytosis in erythroid cells, and is required for efficient clathrin coat maturation (shown by freeze-etch EM). Picalm deletion abrogates disease phenotype in a Jak2(V617F) polycythemia vera mouse model.\",\n      \"method\": \"Conditional Picalm knockout mice, PIP2-binding domain mutant, freeze-etch electron microscopy, live-cell imaging, erythroid culture system, Jak2(V617F) knock-in mouse model\",\n      \"journal\": \"Haematologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — conditional KO mice with domain mutagenesis, structural imaging (freeze-etch EM), and disease model rescue; multiple orthogonal methods\",\n      \"pmids\": [\"25552701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PICALM physically associates with both ABCB1/P-glycoprotein and LRP1 at brain endothelium (shown by co-immunoprecipitation and co-immunostaining), functionally linking these two Aβ clearance proteins and guiding their coordinated transcytosis of Aβ through endothelial cells.\",\n      \"method\": \"Co-immunoprecipitation, co-immunostaining, dual inhibition of ABCB1/P-gp and LRP1\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and co-immunostaining with functional dual-inhibition experiment, single lab\",\n      \"pmids\": [\"30041013\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PICALM depletion by siRNA in H4 neuroglioma cells reduces functional clathrin-mediated endocytosis (measured by Alexa488-transferrin uptake), reduces intracellular APP, β-CTF, and secreted sAPPβ, and decreases BACE1 mRNA and protein levels. PICALM depletion alters intracellular distribution of clathrin.\",\n      \"method\": \"siRNA knockdown of PICALM and clathrin, Western blotting, ELISA, immunohistochemistry, flow cytometry for transferrin uptake\",\n      \"journal\": \"BMC neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple readouts (endocytosis assay, Western blot, ELISA) in single lab, human brain-derived cell line\",\n      \"pmids\": [\"27430330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PICALM interacts with APP via the APP NPXY-motif (interaction abolished by NPXY mutation, shown by co-immunoprecipitation). PTB-domain-containing adaptor proteins Numb, JIP1b, and GULP1 interact with PICALM and enhance the APP-PICALM interaction. Co-expression of distinct PTB-APs differentially alters APP cell surface levels, endocytosis rates, and PICALM nuclear shuttling.\",\n      \"method\": \"Co-immunoprecipitation with APP NPXY-motif mutation, FACS analysis, internalization assays, fluorescence microscopy for nuclear localization\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — co-IP with mutagenesis of APP NPXY motif plus functional endocytosis assays, single lab\",\n      \"pmids\": [\"31300465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Increased expression of PICALM (or its yeast homolog Yap1802p) rescues APOE4-induced endocytic defects in human iPSC-derived astrocytes, demonstrating a functional interaction between two AD risk factors centered on endocytosis. In yeast, APOE4 expression causes dose-dependent defects in endocytosis and growth that are rescued by Yap1802p overexpression.\",\n      \"method\": \"iPSC-derived human astrocytes (isogenic APOE3/APOE4), yeast model with APOE4 expression, Yap1802p overexpression, endocytosis assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue in both yeast and human iPSC-derived astrocytes, two orthogonal model systems, single lab\",\n      \"pmids\": [\"33027662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Picalm haploinsufficiency in Tg30 tau transgenic mice (Tg30xPicalm+/-) significantly aggravates tau pathology: higher pathological tau levels, increased neurofibrillary tangle density, more severe motor deficits, and increased autophagy marker abnormalities compared to Tg30 mice.\",\n      \"method\": \"Transgenic mouse cross (Tg30 x Picalm+/-), behavioral testing, immunohistochemistry for tau pathology, Western blotting for autophagy markers\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic epistasis with tau transgenic model, multiple quantitative readouts (behavior, histology, biochemistry), single lab with rigorous design\",\n      \"pmids\": [\"31925534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Loss-of-function mutations in the mouse Picalm gene (nonsense/splice-donor mutations causing exon deletions) cause hematopoietic abnormalities, growth retardation, abnormal iron metabolism, and shortened lifespan, establishing PICALM as essential for clathrin-mediated endocytosis-dependent hematopoiesis and iron metabolism in vivo.\",\n      \"method\": \"ENU mutagenesis screen, Sanger sequencing of Picalm mutant alleles, genetic mapping, molecular characterization of splice variants\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic loss-of-function (multiple alleles) with defined molecular lesions and concordant phenotypes across alleles\",\n      \"pmids\": [\"12832620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PICALM disruption (CRISPR/Cas9 exon 1 knockout in HeLa cells) increases numbers of early endosomes, increases abundance of lysosomal enzymes in endosome-enriched fractions, disrupts processing and maturation of cathepsin D, and causes autophagy deficits, establishing PICALM as required for correct maturation of lysosomal enzymes.\",\n      \"method\": \"CRISPR/Cas9 knockout, proteomics of endosome-enriched fractions, Western blotting for cathepsin D processing, immunofluorescence\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with proteomic readout and Western blot validation, single lab, single cell type\",\n      \"pmids\": [\"34311200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PICALM modulates cellular cholesterol homeostasis: loss of PICALM increases cellular cholesterol pool size (by GC-MS), alters net scavenging of cholesterol, and enhances LDL receptor internalization due to elevated LDLR expression (confirmed by flow cytometry). PICALM influences expression of genes encoding proteins in cholesterol biosynthesis and lipoprotein uptake pathways.\",\n      \"method\": \"Gene expression studies in PICALM-deficient vs expressing cells, GC-MS cholesterol quantification, isotopic labeling studies, flow cytometry for LDLR internalization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (transcriptomics, GC-MS, isotopic labeling, flow cytometry), single lab\",\n      \"pmids\": [\"26075887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In Drosophila, increased expression of the PICALM orthologue lap rescues Aβ42 toxicity (glutamatergic neurotransmission defects, survival, behavioral function) without affecting Aβ42 levels. lap modulates presynaptic vesicular glutamate transporter (VGlut) accumulation and spontaneous glutamate release, and modulates the localization of amphiphysin (BIN1 homologue), which in turn affects postsynaptic glutamate receptor localization.\",\n      \"method\": \"Drosophila transgenic model, electrophysiology, behavioral assays, confocal imaging of VGlut and GluRII, genetic interaction with Amph/BIN1\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue in Drosophila with electrophysiology and imaging, genetic epistasis with BIN1 homologue, single lab\",\n      \"pmids\": [\"32592479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Artesunate elevates PICALM mRNA and protein levels in endothelial cells and brain capillaries in vivo. In Picalm+/-;5XFAD mice, artesunate increases capillary PICALM levels, reduces Aβ levels and plaque load, and accelerates Aβ clearance from brain to blood. Endothelial-specific PICALM knockout abolishes all beneficial effects, confirming that endothelial PICALM is required for artesunate's therapeutic effects on Aβ pathology.\",\n      \"method\": \"FDA-approved drug screen (2007 compounds, luciferase/PICALM promoter assay), endothelial cell mRNA screen, Picalm+/-;5XFAD mice, Picalmlox/lox;Cdh5-Cre;5XFAD mice, Aβ ELISA, behavioral tests, CBF measurements\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — endothelial-specific conditional KO abolishes drug effect (epistasis), multiple quantitative in vivo readouts, rigorous genetic controls\",\n      \"pmids\": [\"36707892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"High glucose induces ROS-stimulated Sp1 activation, upregulating PICALM, clathrin heavy chain, and AP2α1, resulting in increased lipid raft-mediated APP endocytosis and early endosomal enlargement that increases Aβ production. PICALM facilitates clathrin-mediated APP endocytosis leading to endosomal enlargement under high glucose conditions.\",\n      \"method\": \"Human neuroblastoma cells under high glucose, siRNA knockdown of PICALM, ROS inhibition, Sp1 inhibition, diabetic mouse model with pharmacological inhibitors, immunofluorescence, Aβ ELISA\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — mechanistic pathway dissection by siRNA and inhibitors in cell lines with in vivo validation, single lab\",\n      \"pmids\": [\"32436237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In microglia, the PICALM LOAD-risk allele of rs10792832 reduces PU.1 transcription factor binding and PICALM expression, impairing uptake of Aβ and myelin debris. Reduced PICALM expression in microglia causes lipid droplet (LD) accumulation and phagocytosis deficits. Genetic and pharmacological perturbation established a causal link between reduced PICALM, LD accumulation, and phagocytosis deficits in a microglial-specific manner.\",\n      \"method\": \"Allele-specific open chromatin mapping in iPSC-derived microglia/neurons/astrocytes, genetic PICALM perturbation, pharmacological perturbation, transcriptomic analysis, lipid droplet quantification, phagocytosis assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — allele-specific chromatin mapping plus genetic and pharmacological perturbations with multiple functional readouts, iPSC-derived human microglia, published in Nature\",\n      \"pmids\": [\"40903578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PICALM is upregulated in cardiomyocytes during doxorubicin-induced cardiotoxicity and promotes Aβ peptide generation, increasing cardiomyocyte membrane permeability. Genetic depletion and pharmacological blocking peptides targeting PICALM reduce Aβ generation and alleviate doxorubicin-induced cardiotoxicity in vitro and in vivo.\",\n      \"method\": \"Single cell/nucleus RNA sequencing, doxorubicin mouse model, genetic Picalm depletion, pharmacological blocking peptides, membrane permeability assays, human heart tissue verification\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — single-cell sequencing plus in vivo genetic and pharmacological intervention, human tissue confirmation, single lab\",\n      \"pmids\": [\"38935046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"siRNA-mediated knockdown of Picalm in mature 3T3-L1 adipocytes amplifies insulin-stimulated GLUT4 translocation to the plasma membrane and increases phosphorylation of Akt and Tbc1d4. Picalm depletion before and during differentiation suppresses adipogenesis. Picalm knockdown decreases clathrin-dependent EGF uptake and increases abundance of vesicular trafficking and actin remodeling proteins at the plasma membrane.\",\n      \"method\": \"siRNA knockdown in 3T3-L1 adipocytes and C2C12 myoblasts, GLUT4 translocation assay, insulin signaling (Akt/Tbc1d4 phosphorylation), EGF internalization assay, plasma membrane proteomics\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — siRNA KD with multiple functional assays (translocation, signaling, endocytosis, proteomics), single lab\",\n      \"pmids\": [\"39182843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Picalm depletion in C2C12 myoblasts impairs differentiation through diminished intracellular trafficking dynamics, decreased clathrin-dependent EGF uptake, and increased plasma membrane abundance of vesicular trafficking proteins (Vamp3, Vamp5) and actin remodeling proteins (Actn1, Actn4, Rhog, Rock1, Rock2). Pharmacological stabilization of actin filaments with Jasplakinolide rescues myogenic differentiation in Picalm-deficient cells, establishing a functional link between PICALM-dependent endocytosis, actin remodeling, and myogenesis.\",\n      \"method\": \"siRNA knockdown in C2C12 myoblasts and primary myocytes, EGF internalization assay, dynamin inhibition (Dyngo-4a), plasma membrane proteomics, Jasplakinolide rescue, autophagy assays\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phenotypic rescue by actin stabilization provides mechanistic epistasis, multiple orthogonal methods (proteomics, endocytosis assay, pharmacological rescue), single lab\",\n      \"pmids\": [\"41833602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PICALM knockout by CRISPR-Cas9 screen in CD4+ SupT1 T cells inhibits HIV-1 viral entry and causes defects in intracellular trafficking, increased intracellular Gag accumulation, alterations in autophagy, immune checkpoint PD-1 levels, and differentiation markers, establishing PICALM as a host factor required for HIV-1 entry and intracellular trafficking.\",\n      \"method\": \"CRISPR-Cas9 screen of 140 membrane trafficking proteins, PICALM KO in SupT1 cells, HIV-1 infection assays, flow cytometry, immunofluorescence\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — CRISPR KO with multiple functional readouts in single lab, identified via unbiased screen\",\n      \"pmids\": [\"38957789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PICALM localizes to both presynaptic active zones and postsynaptic endocytic zones, co-localizes with APP, and forms nanodomains with distinct morphological properties in different subsynaptic regions. Elevated PICALM expression differentially alters lateral diffusion of APP C-terminal deletion mutants, indicating PICALM regulates APP nanoscale dynamics via the APP C-terminal Y682ENPTY687 domain.\",\n      \"method\": \"Single-molecule super-resolution imaging (STORM/PALM), single-particle tracking, APP C-terminal deletion mutants, co-localization analysis in neurons\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — super-resolution imaging with domain mutants, single lab, mechanistic link between PICALM and APP nanodomain dynamics\",\n      \"pmids\": [\"37726569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PICALM knockdown in uninfected cells increases cholesterol in Golgi and TfR-positive recycling endosomes. In Chlamydia-infected cells, PICALM knockdown increases Golgi-derived lipid/protein, TfR, transferrin, and Rab11-FIP1 localized to chlamydial inclusions and decreases Rab11 trafficking to the inclusion, establishing PICALM as a regulator of cholesterol homeostasis and endosomal recycling pathway trafficking to the chlamydial inclusion.\",\n      \"method\": \"siRNA knockdown of PICALM in infected and uninfected cells, immunofluorescence for cholesterol/Golgi/TfR/Rab11 markers, quantitative imaging\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA knockdown with multiple trafficking readouts, single lab, mechanistic specificity of PICALM in endosomal recycling\",\n      \"pmids\": [\"36779337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SRSF6 regulates alternative splicing of PICALM exon 14, triggering a switch from short to long PICALM isoform (PICALML). CRNDE lncRNA reduces SRSF6 protein stability, thereby affecting this splicing event. Expression of PICALML contributes to autophagy regulation and chemosensitivity in gastric cancer cells.\",\n      \"method\": \"RNA splicing analysis, siRNA knockdown of SRSF6, CRNDE overexpression/knockdown, isoform-specific expression analysis, autophagy flux assays\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — mechanistic splicing regulation identified by multiple methods, but focused on lncRNA-mediated regulation rather than PICALM protein mechanism per se\",\n      \"pmids\": [\"33397371\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PICALM is a clathrin-adaptor protein that drives clathrin-mediated endocytosis by recruiting clathrin and AP2 to the plasma membrane via its phosphatidylinositol (PIP2)-binding domain; it regulates internalization of multiple cargoes including transferrin receptor (controlling iron homeostasis in erythroid cells), APP/LRP1 (controlling Aβ production and BBB transcytosis), and SNARE proteins (VAMP2/3/8), thereby modulating autophagosome formation and lysosomal maturation; in brain endothelium, PICALM links LRP1 and ABCB1/P-gp to guide Aβ transcytosis and clearance, and in microglia the AD-risk allele (rs10792832) reduces PU.1-driven PICALM expression, impairing phagocytosis and causing pathological lipid droplet accumulation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PICALM is a clathrin-adaptor protein that drives clathrin-mediated endocytosis through its PIP2-binding domain and C-terminal clathrin-association motif, governing the internalization of multiple cell-surface cargoes [#5, #7]. Its best-defined housekeeping role is in transferrin receptor uptake and iron homeostasis: PICALM loss raises surface TfR, lowers intracellular iron, and impairs erythroid maturation, with the PIP2-binding domain essential for clathrin coat maturation and erythroid development in vivo [#5, #6, #7], consistent with the hematopoietic and iron-metabolism defects of mouse loss-of-function alleles [#13]. Beyond endocytosis, PICALM controls autophagy by regulating endocytosis of the SNARE proteins VAMP2/3/8, thereby setting autophagosome formation and degradation and clearance of the autophagy substrate tau [#1], and acts within an AP2/PICALM cargo receptor that binds LC3 to route APP-CTF toward autophagic degradation [#2]. PICALM also directs maturation of lysosomal enzymes, including cathepsin D processing [#14], and shapes cellular cholesterol and LDL-receptor handling [#15]. In Alzheimer's-disease-relevant contexts, PICALM binds APP via its NPXY/Y682ENPTY687 motif to control APP internalization, nanoscale dynamics, and Aβ generation [#3, #10, #24], and at the blood-brain barrier it links LRP1 and ABCB1/P-glycoprotein to drive Rab5/Rab11-dependent transcytosis and clearance of Aβ across brain endothelium [#0, #8]; pharmacological elevation of endothelial PICALM with artesunate reduces Aβ pathology in an endothelial-PICALM-dependent manner [#17]. In microglia, an Alzheimer's-risk allele reduces PU.1-driven PICALM expression, impairing phagocytosis of Aβ and myelin debris and causing lipid droplet accumulation [#19], while Picalm haploinsufficiency aggravates tau pathology in vivo [#12].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established that PICALM is genetically essential in vivo by showing loss-of-function alleles cause hematopoietic, growth, and iron-metabolism defects, framing PICALM as a non-redundant endocytic regulator.\",\n      \"evidence\": \"ENU mutagenesis screen with molecularly defined Picalm mutant alleles in mice\",\n      \"pmids\": [\"12832620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the specific cargo or molecular step disrupted\", \"Mechanism linking endocytosis defect to phenotype not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the molecular cargo behind the iron phenotype, showing PICALM drives clathrin-mediated transferrin receptor endocytosis required for erythroid maturation.\",\n      \"evidence\": \"PICALM-deficient/KO mice and MEFs with retroviral rescue, C-terminal deletion mutants, transferrin endocytosis and iron assays\",\n      \"pmids\": [\"22952941\", \"22363754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"C-terminal clathrin-binding region mapped but structural basis not resolved\", \"Did not address non-erythroid cargoes\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated the PIP2-binding domain is the essential functional element for TfR endocytosis and erythroid development and required for clathrin coat maturation.\",\n      \"evidence\": \"Conditional Picalm KO mice with PIP2-domain mutant, freeze-etch EM, Jak2(V617F) polycythemia vera rescue\",\n      \"pmids\": [\"25552701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type specificity of cargo selection not fully explained\", \"Structural mechanism of coat maturation incomplete\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended PICALM beyond cargo uptake to autophagy regulation by identifying SNARE proteins (VAMP2/3/8) as endocytic substrates affecting distinct autophagy stages.\",\n      \"evidence\": \"siRNA/overexpression in cell lines plus zebrafish transgenic tau-clearance models\",\n      \"pmids\": [\"25241929\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct interaction interface with each VAMP not defined\", \"Stage-specific contribution of each SNARE not separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed PICALM acts in an AP2-containing autophagic cargo receptor that bridges LC3 and APP-CTF, providing a molecular route from endocytosis to autophagic degradation.\",\n      \"evidence\": \"Affinity purification/MS, co-IP, siRNA knockdown, live imaging\",\n      \"pmids\": [\"24067654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and direct LC3-binding determinant on PICALM vs AP2 not resolved\", \"In vivo relevance not tested here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Connected PICALM to amyloid biology by showing it controls APP internalization and bidirectionally sets Aβ production in cells and APP/PS1 mice.\",\n      \"evidence\": \"siRNA/overexpression in N2a-APP cells, AAV8 shRNA/cDNA in APP/PS1 mice, colocalization and ELISA\",\n      \"pmids\": [\"22539346\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the APP-PICALM binding determinant\", \"Did not distinguish neuronal vs vascular contributions\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified PICALM as a blood-brain-barrier clearance factor that internalizes LRP1-bound Aβ through Rab5/Rab11 endosomes for transcytosis.\",\n      \"evidence\": \"Human and iPSC endothelial monolayers, Picalm-deficient mice with adenoviral rescue, live imaging\",\n      \"pmids\": [\"26005850\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify all endothelial partners coordinating transcytosis\", \"Directionality control of transcytosis not fully resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked PICALM to tau pathology, showing PICALM is proteolytically cleaved and depleted in AD brain and associates with PHF-tau.\",\n      \"evidence\": \"Western blot, in vitro calpain/caspase cleavage assay, IHC, co-IP from AD brain\",\n      \"pmids\": [\"23589030\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP without reciprocal validation; directness of PICALM-tau interaction unclear\", \"Functional consequence of cleavage not established\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Broadened PICALM's lipid trafficking role to cholesterol homeostasis and LDL-receptor handling.\",\n      \"evidence\": \"Transcriptomics, GC-MS cholesterol quantification, isotopic labeling, flow cytometry for LDLR internalization\",\n      \"pmids\": [\"26075887\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which PICALM alters cholesterol-gene expression unknown\", \"Single lab, single cell context\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided the endothelial protein-interaction basis for Aβ clearance, showing PICALM physically links LRP1 and ABCB1/P-gp.\",\n      \"evidence\": \"Co-IP, co-immunostaining, dual ABCB1/LRP1 inhibition in brain endothelium\",\n      \"pmids\": [\"30041013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP/co-staining without direct binding-site mapping\", \"Whether interaction is direct or scaffolded not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the APP-PICALM interaction at the NPXY motif and showed PTB-domain adaptors (Numb, JIP1b, GULP1) tune the interaction, surface APP, and PICALM nuclear shuttling.\",\n      \"evidence\": \"Co-IP with APP NPXY mutation, FACS, internalization assays, fluorescence microscopy\",\n      \"pmids\": [\"31300465\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of PICALM nuclear shuttling unknown\", \"Single lab without in vivo confirmation\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established genetic epistasis with tau pathology, showing Picalm haploinsufficiency aggravates tau accumulation and motor deficits in vivo.\",\n      \"evidence\": \"Tg30 x Picalm+/- mouse cross, behavior, IHC, autophagy-marker Western blots\",\n      \"pmids\": [\"31925534\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate autophagy from endocytic contributions to tau handling\", \"Cell-type origin of effect not dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Positioned PICALM as a convergence node for AD risk by showing its overexpression rescues APOE4-induced endocytic defects across yeast and human astrocytes.\",\n      \"evidence\": \"Isogenic APOE3/APOE4 iPSC astrocytes and yeast Yap1802p rescue, endocytosis assays\",\n      \"pmids\": [\"33027662\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target of the APOE4 endocytic defect not identified\", \"Astrocyte-specific consequences in vivo untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed PICALM is required for lysosomal enzyme maturation, linking it to endosome-to-lysosome processing and autophagy.\",\n      \"evidence\": \"CRISPR/Cas9 PICALM KO in HeLa, proteomics of endosome fractions, cathepsin D Western blot\",\n      \"pmids\": [\"34311200\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting endocytic defect to cathepsin D mis-processing unclear\", \"Single cell type\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved PICALM's subsynaptic organization, showing it forms nanodomains at pre- and postsynaptic zones and controls APP nanoscale dynamics via the APP C-terminal motif.\",\n      \"evidence\": \"STORM/PALM super-resolution imaging, single-particle tracking, APP C-terminal mutants in neurons\",\n      \"pmids\": [\"37726569\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional readout of altered APP diffusion not measured\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Provided in vivo therapeutic proof-of-concept that elevating endothelial PICALM clears Aβ, with the effect strictly dependent on endothelial PICALM.\",\n      \"evidence\": \"FDA drug screen identifying artesunate, Picalm+/-;5XFAD and endothelial conditional KO mice, Aβ ELISA, CBF\",\n      \"pmids\": [\"36707892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which artesunate raises PICALM transcription incompletely defined\", \"Long-term safety/efficacy not addressed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected the AD-risk variant to microglial dysfunction, showing rs10792832 reduces PU.1-driven PICALM expression, impairing phagocytosis and causing lipid droplet accumulation.\",\n      \"evidence\": \"Allele-specific open-chromatin mapping in iPSC microglia/neurons/astrocytes, genetic and pharmacological perturbation, phagocytosis and lipid droplet assays\",\n      \"pmids\": [\"40903578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How reduced endocytosis mechanistically drives lipid droplet buildup not fully resolved\", \"Other risk-allele effects on non-microglial cells not addressed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended PICALM's functional reach to peripheral systems, implicating it in HIV-1 entry, doxorubicin cardiotoxicity, and adipocyte insulin/GLUT4 signaling.\",\n      \"evidence\": \"CRISPR screen in CD4+ T cells; scRNA-seq plus Picalm depletion in doxorubicin cardiotoxicity; siRNA in 3T3-L1 adipocytes with GLUT4 and insulin-signaling assays\",\n      \"pmids\": [\"38957789\", \"38935046\", \"39182843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether these reflect a single shared endocytic mechanism unclear\", \"Direct molecular partners in each context not mapped\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Tied PICALM-dependent endocytosis to actin remodeling and myogenesis by showing actin stabilization rescues differentiation in PICALM-deficient myoblasts.\",\n      \"evidence\": \"siRNA in C2C12/primary myocytes, EGF internalization, plasma membrane proteomics, Jasplakinolide rescue\",\n      \"pmids\": [\"41833602\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical link between PICALM and actin machinery not demonstrated\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PICALM selects among its diverse cargoes (TfR, APP, SNAREs, LDLR, GLUT4) in a cell-type-specific manner, and the structural determinants distinguishing these interactions, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model of cargo selectivity\", \"Isoform-specific functions (e.g., PICALML) largely uncharacterized\", \"Mechanism coupling PICALM endocytosis to autophagy and lysosomal maturation not fully defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 5, 7]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [7, 15]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 7, 18, 24]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0, 14, 25]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [5, 6, 7, 9]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [1, 2, 14]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 3, 12, 19]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"complexes\": [\n      \"AP2/PICALM clathrin adaptor complex\"\n    ],\n    \"partners\": [\n      \"AP2\",\n      \"LRP1\",\n      \"ABCB1\",\n      \"APP\",\n      \"VAMP2\",\n      \"VAMP3\",\n      \"VAMP8\",\n      \"LC3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":6,"faith_total":6,"faith_pct":100.0}}